Contents
Volume 2, Issue 4 APRIL 2020

COLUMNS
EPIDEMIOLOGY & THERAPEUTICS …….…………………….…………….…………………………………………………………………………….5
Innovations in Therapeutics to Control COVID-19
https://doi.org/10.37756/bk.20.2.4.1
MEDICAL DIAGNOSTICS FOR COVID-19 ………………….……………………..…..………………………………………………………………..14
The Need for Next Generation Diagnostic and Surveillance Technologies to Battle SARSCoV-2 Pandemic
https://doi.org/10.37756/bk.20.2.4.2
FOOD & HEALTH SCIENCE ……………………………………………………..………..….………………………………………………………………23
The tussle between the developing adolescent brain and dietary choices: who’s the target who’s the trigger?
https://doi.org/10.37756/bk.20.2.4.3
OPINION……………………..………………………………………….…………..……….………………………………………………………………………29
A Proposed Herbal Formulation: Targeting to Strengthen Inner Immunity to Fight Infectious Diseases

BIOTECH R&D AND INNOVATION NEWS…………………………………….……………….………………………………………………………33
Editor’s PICKS: Biotechnology Advances around the World
Neurology….……………………………………..……………………………………………………………………………………………………………………34
Regenerative Medicine and Tissue Engineering…..……..………………………….…………………………………………………………………..34
Nutritional & Environmental Biotechnology..…………………….…….……….……………………………………………………………………….35
Biorecycling & Microbiology……………………………………………………………………………………………………………………………………..35

BIOTECH AND PHARMA INDUSTRY ROUNDUP..……………………………………….………………………………………………………………37
Dynavax & Sinovac to jointly develop COVID-19 vaccine candidate.……………..……………………………………………………………….37
Eagle Pharma to test Ryanodex against COVID-19……………………………………………………………………………………………………….37
Meningococcal Vaccines …………………………..………………….…….……………………………………………………………………………………….37
AstraZeneca’s Imfinzi shows promise in lung cancer……………………..……………….………………………………………………………………37
UroGen’s Jelmyto gets expedited approval from FDA.………………………………..………………………………………………………………….37
SMA drug gets a boost……………………………………………..……………………..…………………………………………………………………………..38
AstraZeneca to study leukemia drug as COVID-19 treatment………………………..………………………………………………………………….38
$125M donation to speed coronavirus treatments ……….…………..…………………………………………………………………………………….38
Investments to counter Cancer genes…………………………………..…………………………………………………………………………………………38
Roche presents biomarker for cancer.……………………………..……………………..……………………………………………………………………….39
French company Stilla raises €20M …….……………………………………………..…………………………………………………………………………39
HALIX B.V. to produce vaccines against COVID-19………………………………………………………………………………………………………..39

ADVERTISING INFORMATION………………………………………………………………………………………………………………………………….40
(a) WEB BANNER AND ADVERTISEMENT RATES
(b) GENERAL AD RATES FOR THE MAGAZINE